The beneficial effects of metformin on cancer prevention and therapy: a comprehensive review of recent advances

P Saraei, I Asadi, MA Kakar… - Cancer management and …, 2019 - Taylor & Francis
Metformin is a widely used drug in today's prescriptions by physicians due to its specific
effects in treating and curing type II diabetes. Diabetes is a common disease that may occur …

[HTML][HTML] ROS homeostasis and metabolism: a dangerous liason in cancer cells

E Panieri, MM Santoro - Cell death & disease, 2016 - nature.com
Tumor cells harbor genetic alterations that promote a continuous and elevated production of
reactive oxygen species. Whereas such oxidative stress conditions would be harmful to …

[HTML][HTML] Targeting OXPHOS and the electron transport chain in cancer; Molecular and therapeutic implications

J Greene, A Segaran, S Lord - Seminars in Cancer Biology, 2022 - Elsevier
Oxidative phosphorylation (OXPHOS) takes place in mitochondria and is the process
whereby cells use carbon fuels and oxygen to generate ATP. Formerly OXPHOS was …

Targeting mitochondria metabolism for cancer therapy

SE Weinberg, NS Chandel - Nature chemical biology, 2015 - nature.com
Mitochondria have a well-recognized role in the production of ATP and the intermediates
needed for macromolecule biosynthesis, such as nucleotides. Mitochondria also participate …

Metformin-induced stromal depletion to enhance the penetration of gemcitabine-loaded magnetic nanoparticles for pancreatic cancer targeted therapy

H Han, Y Hou, X Chen, P Zhang, M Kang… - Journal of the …, 2020 - ACS Publications
Pancreatic ductal adenocarcinoma, as one of the most aggressive cancers, is characterized
by rich desmoplastic stroma that forms a physical barrier for anticancer drugs. To address …

Facilitative glucose transporters: Implications for cancer detection, prognosis and treatment

CC Barron, PJ Bilan, T Tsakiridis, E Tsiani - Metabolism, 2016 - Elsevier
It is long recognized that cancer cells display increased glucose uptake and metabolism. In
a rate-limiting step for glucose metabolism, the glucose transporter (GLUT) proteins facilitate …

Metformin in combination with chemoradiotherapy in locally advanced non–small cell lung cancer: The OCOG-ALMERA randomized clinical trial

T Tsakiridis, GR Pond, J Wright, PM Ellis… - JAMA …, 2021 - jamanetwork.com
Importance Unresected locally advanced non–small cell lung cancer (LA-NSCLC) shows
poor survival outcomes even after aggressive concurrent chemoradiotherapy. Whether …

[HTML][HTML] Repurposing metformin for cancer treatment: current clinical studies

YK Chae, A Arya, MK Malecek, DS Shin, B Carneiro… - Oncotarget, 2016 - ncbi.nlm.nih.gov
In recent years, several studies have presented evidence suggesting a potential role for
metformin in anti-cancer therapy. Preclinical studies have demonstrated several anticancer …

[HTML][HTML] Effects of hyperglycemia on the progression of tumor diseases

W Li, X Zhang, H Sang, Y Zhou, C Shang… - Journal of Experimental …, 2019 - Springer
Malignant tumors are often multifactorial. Epidemiological studies have shown that
hyperglycemia raises the prevalence and mortality of certain malignancies, like breast, liver …

Addition of metformin to concurrent chemoradiation in patients with locally advanced non–small cell lung cancer: The NRG-LU001 phase 2 randomized clinical trial

H Skinner, C Hu, T Tsakiridis, R Santana-Davila… - JAMA …, 2021 - jamanetwork.com
Importance Non–small cell lung cancer (NSCLC) has relatively poor outcomes. Metformin
has significant data supporting its use as an antineoplastic agent. Objective To compare …